Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector

Abstract

AAV9-ANF vectors produce efficient, dose-dependent, and atrial-specific gene expression following a single-dose systemic delivery in mice. This vector is a novel reagent for both mechanistic and gene therapy studies on atrial diseases.